Article ID Journal Published Year Pages File Type
8745782 Indian Journal of Tuberculosis 2018 15 Pages PDF
Abstract
Nearly half of the multi drug resistant (MDR) tuberculosis patients (44.22%) being treated on category IV regimen also have resistance to either fluoroquinolones or aminoglycosides or both i.e. Pre XDR or XDR. This may result in poor outcome of category IV regimen under RNTCP. There is a strong need for provision of culture sensitivity for all first line drugs and at least two second line drugs viz. Fluoroquinolones and aminoglycosides for all the patients registered as smear positive under RNTCP. There is also a need for development of rapid culture technique for sensitivity to second line drugs.
Related Topics
Health Sciences Medicine and Dentistry Infectious Diseases
Authors
, , , , , , ,